Is Radiation Therapy Needed in the Treatment of Gastroesophageal Junction Adenocarcinoma?

Por Tepper, Joel E.
Publicado em 2008

Clinical Medicine and Clinical Trials

Por Tepper, Joel E.
Publicado em 2010

The Future of Cooperative Clinical Research in Gastrointestinal Oncology

Por Tepper, Joel E.
Publicado em 2012

Gastrointestinal Cancers and the Cooperative Groups–2011

Por Tepper, Joel E.
Publicado em 2012

Crossroads in the Combined-Modality Management of Gastroesophageal Junction Carcinomas

Por Apisarnthanarax, Smith, Tepper, Joel E.
Publicado em 2008

Nanotechnology in Radiation Oncology

Por Wang, Andrew Z., Tepper, Joel E.
Publicado em 2014

Radiation Oncology: A Snapshot in Time, 2014

Por Kavanagh, Brian D., Haffty, Bruce G., Tepper, Joel E.
Publicado em 2014

Practice Patterns and Long-Term Survival for Early-Stage Rectal Cancer

Por Stitzenberg, Karyn B., Sanoff, Hanna K., Penn, Dolly C., Meyers, Michael O., Tepper, Joel E.
Publicado em 2013

Postoperative Irradiation for Rectal Cancer Increases the Risk of Small Bowel Obstruction After Surgery

Por Baxter, Nancy N., Hartman, Lacey K., Tepper, Joel E., Ricciardi, Rocco, Durham, Sara B., Virnig, Beth A.
Publicado em 2007

Wound Complications in Preoperatively Irradiated Soft-Tissue Sarcomas of the Extremities

Por Rosenberg, Lewis A., Esther, Robert J., Erfanian, Kamil, Green, Rebecca, Kim, Hong Jin, Sweeting, Raeshell, Tepper, Joel E.
Publicado em 2012

NF-κB and Bcl-3 Activation Are Prognostic in Metastatic Colorectal Cancer

Por Puvvada, Soham D., Funkhouser, William K., Greene, Kevin, Deal, Allison, Chu, Haitao, Baldwin, Albert S., Tepper, Joel E., O'Neil, Bert H.
Publicado em 2010

Radiosensitization of EGFR/HER2 positive pancreatic cancer is mediated by inhibition of Akt independent of Ras mutational status

Por Kimple, Randall J., Vaseva, Angelina V., Cox, Adrienne D., Baerman, Kathryn M., Calvo, Benjamin F., Tepper, Joel E., Shields, Janiel M., Sartor, Carolyn I.
Publicado em 2010

A Phase II Trial of Gemcitabine, 5-Florouracil, and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma: Cancer and Leukemia Group B (CALGB) 80003

Por Mamon, Harvey J., Niedzwiecki, Donna, Hollis, Donna, Tan, Benjamin R., Mayer, Robert J., Tepper, Joel E., Goldberg, Richard M., Blackstock, A. William, Fuchs, Charles S.
Publicado em 2010

Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck

Por Apisarnthanarax, Smith, Dhruva, Nirav, Ardeshirpour, Farhad, Tepper, Joel E., Shores, Carol G., Rosenman, Julian G., Shockley, William W., Hayward, Michele C., Hayes, D. Neil
Publicado em 2011

A two-cohort phase 1 study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine and erlotinib during radiotherapy for unresectable pancreatic carcinoma

Por Raftery, Laura, Tepper, Joel E, Goldberg, Richard M., Blackstock, A. William, Aklilu, Mebea, Bernard, Stephen A., Ivanova, Anastasia, Davies, Janine M., O’Neil, Bert H.
Publicado em 2013

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy

Por Davies, Janine M, Trembath, Dimitri, Deal, Allison M, Funkhouser, William K, Calvo, Benjamin F, Finnegan, Timothy, Weck, Karen E, Tepper, Joel E, O'Neil, Bert H
Publicado em 2011

Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma

Por Sweeting, Raeshell S., Deal, Allison M., Llaguna, Omar H., Bednarski, Brian K., Meyers, Michael O., Yeh, Jen Jen, Calvo, Benjamin F., Tepper, Joel E., Kim, Hong Jin
Publicado em 2013

CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF-1α

Por Tian, Xi, Nguyen, Minh, Foote, Henry P., Caster, Joseph M., Roche, Kyle C., Peters, Christian G., Wu, Pauline, Jayaraman, Lata, Garmey, Edward G., Tepper, Joel E., Eliasof, Scott, Wang, Andrew Z.
Publicado no Cancer Res (2016)

NF-κB is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiation

Por O’Neil, Bert H., Funkhouser, William K., Calvo, Benjamin F., Meyers, Michael O., Kim, Hong Jin, Goldberg, Richard M., Bernard, Stephen A., Caskey, Laura, Deal, Allison M., Wright, Fred, Baldwin, Albert S., Tepper, Joel E.
Publicado em 2010

A Phase I Study of Bortezomib in Combination With Standard 5-Fluorouracil and External-Beam Radiation Therapy for the Treatment of Locally Advanced or Metastatic Rectal Cancer

Por O’Neil, Bert H., Raftery, Laura, Calvo, Benjamin F., Chakravarthy, A. Bapsi, Ivanova, Anastasia, Myers, Michael O., Kim, Hong Jin, Chan, Emily, Wise, Paul E., Caskey, Laura S., Bernard, Stephen A., Sanoff, Hanna K., Goldberg, Richard M., Tepper, Joel E.
Publicado em 2010